Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Regulatory status of selected anti-migraine medication worldwide as of 2011, by drug type*
Medication: regulatory status of specific anti-migraine drugs around the world 2011
This statistic displays the regulatory status of specific migraine medications worldwide as of 2011. In 23 percent of responding countries, the anti-migraine drug Ergotamine is available on the over-the-counter market.
Regulatory status of selected anti-migraine medication worldwide as of 2011, by drug type*
Over-the-counter (OTC)GP's prescription neededSpecialists prescription needed
----
----
----
----
----
----
----
----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2011

Region

Worldwide

Survey time period

2006 to 2009

Age group

Supplementary notes

* The source states that information was collected in a questionnaire survey of neurologists, general practitioners and patients’ representatives from 101 countries, performed from October 2006 until March 2009. Epidemiological data were compiled from published studies through a systematic review, and supplemented by data gathered in population-based studies undertaken within the Global Campaign.

Medication: regulatory status of specific anti-migraine drugs around the world 2011
This statistic displays the regulatory status of specific migraine medications worldwide as of 2011. In 23 percent of responding countries, the anti-migraine drug Ergotamine is available on the over-the-counter market.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Headache and migraine in the U.S."
  • Prevalence
  • Migraines
  • Migraine symptoms/comorbidities
  • Migraine impacts
  • Relief
  • Top analgesic tablet brands
  • Miscellaneous
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.